Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verastem (VSTM) Revenue (2018 - 2025)

Historic Revenue for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $11.2 million.

  • Verastem's Revenue changed N/A to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 7035.27%. This contributed to the annual value of $10.0 million for FY2024, which is 34160.43% up from last year.
  • Latest data reveals that Verastem reported Revenue of $11.2 million as of Q3 2025.
  • Over the past 5 years, Verastem's Revenue peaked at $11.2 million during Q3 2025, and registered a low of -$1.1 million during Q1 2024.
  • Its 5-year average for Revenue is $1.7 million, with a median of $251000.0 in 2021.
  • As far as peak fluctuations go, Verastem's Revenue plummeted by 2812500.0% in 2023, and later soared by 99206.07% in 2024.
  • Quarter analysis of 5 years shows Verastem's Revenue stood at $545000.0 in 2021, then tumbled by 100.73% to -$4000.0 in 2022, then crashed by 28125.0% to -$1.1 million in 2023, then skyrocketed by 985.74% to $10.0 million in 2024, then grew by 12.42% to $11.2 million in 2025.
  • Its last three reported values are $11.2 million in Q3 2025, $2.1 million for Q2 2025, and -$192000.0 during Q1 2025.